imatinib has been researched along with Leukemia in 4 studies
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, D | 1 |
| Zhang, Z | 1 |
| Lu, X | 1 |
| Feng, Y | 1 |
| Luo, K | 1 |
| Gan, J | 1 |
| Yingxue, L | 1 |
| Wan, J | 1 |
| Li, X | 2 |
| Zhang, F | 1 |
| Tu, Z | 1 |
| Cai, Q | 1 |
| Ren, X | 1 |
| Ding, K | 1 |
| Radi, M | 1 |
| Dreassi, E | 1 |
| Brullo, C | 1 |
| Crespan, E | 1 |
| Tintori, C | 1 |
| Bernardo, V | 1 |
| Valoti, M | 1 |
| Zamperini, C | 1 |
| Daigl, H | 1 |
| Musumeci, F | 1 |
| Carraro, F | 1 |
| Naldini, A | 1 |
| Filippi, I | 1 |
| Maga, G | 1 |
| Schenone, S | 1 |
| Botta, M | 1 |
| Wang, Q | 1 |
| Liu, F | 1 |
| Qi, S | 1 |
| Qi, Z | 1 |
| Yan, XE | 1 |
| Wang, B | 1 |
| Wang, A | 1 |
| Wang, W | 2 |
| Chen, C | 1 |
| Liu, X | 1 |
| Jiang, Z | 1 |
| Hu, Z | 1 |
| Wang, L | 1 |
| Ren, T | 1 |
| Zhang, S | 1 |
| Yun, CH | 1 |
| Liu, Q | 1 |
| Liu, J | 1 |
| Gu, X | 1 |
| Guan, M | 1 |
| Jiang, C | 1 |
| Song, Q | 1 |
| Sun, N | 1 |
| Zou, Y | 1 |
| Zhou, Q | 1 |
| Chen, J | 1 |
| Qiu, J | 1 |
4 other studies available for imatinib and Leukemia
| Article | Year |
|---|---|
Hybrid compounds as new Bcr/Abl inhibitors.
Topics: Cell Line, Tumor; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; Humans; Leukemia; Mode | 2011 |
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Leu | 2011 |
Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRα kinase inhibitor for PDGFRα driving chronic eosinophilic leukemia.
Topics: Acrylamides; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Proliferation; Dose-Respons | 2018 |
Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Prol | 2020 |